Showing results (1-10 of 343) with videos related to
Sort By:
Pageof 35
The Journal of Clinical Investigation|March 2, 2026
IFN signaling at the nexus of the radiotherapy response in malignant peripheral nerve sheath tumorsSean P Pitroda, Ralph R WeichselbaumNature Reviews. Clinical Oncology|May 17, 2019
Integrated molecular and clinical staging defines the spectrum of metastatic cancerSean P Pitroda, Ralph R WeichselbaumThe Lancet. Oncology|August 1, 2024
Radiotherapy, immunity, and immune checkpoint inhibitorsConnor Lynch, Sean P Pitroda, Ralph R WeichselbaumCancer Cell|July 4, 2025
The dark side of radiotherapyAndrás Piffkó, Sean P Pitroda, Ralph R WeichselbaumInternational Journal of Molecular Sciences|September 10, 2021
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May HoldWilliam Tyler Turchan, Sean P Pitroda, Ralph R WeichselbaumNeoplasia (New York, N.Y.)|March 18, 2022
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapyWilliam Tyler Turchan, Sean P Pitroda, Ralph R WeichselbaumThe Lancet. Oncology|August 1, 2019
Integration of radiotherapy and immunotherapy for treatment of oligometastasesSean P Pitroda, Steven J Chmura, Ralph R WeichselbaumClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2021
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future FocusWilliam Tyler Turchan, Sean P Pitroda, Ralph R WeichselbaumCancer|December 7, 2018
Oligometastatic prostate cancer: Reality or figment of imagination?Corey C Foster, Ralph R Weichselbaum, Sean P PitrodaCancer Journal (Sudbury, Mass.)|March 25, 2020
Definition, Biology, and History of Oligometastatic and Oligoprogressive DiseaseCorey C Foster, Sean P Pitroda, Ralph R WeichselbaumPageof 35